# Ocugen

Ocugen is an other based in Malvern, United States.

## Overview

- **Organization type:** other
- **Headquarters:** Malvern, United States
- **Region:** North America
- **Address:** Malvern, United States
- **Assets under management:** Undisclosed
- **Website:** www.ocugen.com
- **LinkedIn:** https://www.linkedin.com/company/ocugen

## Regulatory record

- **Reports private funds:** No

## About

Ocugen is a biotech company based in Aurora, United States, founded in 2013. It specializes in vaccines and gene therapies, focusing on public health and unmet medical needs. The company's platform includes a modifier gene therapy for multiple retinal diseases and ongoing research in COVID-19 vaccine development, with $23.82 million in total funding.

## Questions

### What is Ocugen's primary therapeutic focus?

Ocugen is developing modifier gene therapies for retinal diseases, with lead candidate OCU400 targeting retinitis pigmentosa. The firm also collaborated on a COVID-19 vaccine candidate (Covaxin) through a partnership with Bharat Biotech (per company communications, 2022).

### Which partners support Ocugen's manufacturing and distribution?

Ocugen has partnered with Bharat Biotech, an Indian vaccine manufacturer, for Covaxin development and supply. The company has not disclosed other manufacturing partners for its gene therapy programs beyond general contract manufacturing arrangements.

### Has Ocugen disclosed its AUM or deployment amount?

No. Ocugen does not publicly report assets under management or deployment figures. The firm funds R&D through equity offerings and strategic partnerships, as disclosed in SEC filings.

### What stage of clinical development is Ocugen in?

Ocugen's lead candidate OCU400 was in Phase 3 clinical trials as of 2023, with initial data expected in 2024. The firm also explored regulatory approval for Covaxin under an emergency use authorization pathway in the US.

## Related profiles

- [SIGMAXYZ Inc.](https://altss.com/profile/sigmaxyz-inc)
- [CFGI (UK) Limited](https://altss.com/profile/cfgi-uk-limited)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/ocugen

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology